Remdesivir recalls

The FDA has published 2 recalls involving Remdesivir since 2022. The latest was reported on 9 Oct 2024. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2022

Last 12 months0reported

Class I2100% of total

Ongoing0latest 9 Oct 2024

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 2 100%Class II 0 0%Class III 0 0%

Why remdesivir is recalled

Particulate Matter2100%

Companies

Gilead Sciences2100%

By year

2024150%
2022150%

All remdesivir recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
9 Oct 2024Drug	CLASS I	Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial recalledVeklury	Gilead Sciences	Particulate Matter	Nationwide
5 Jan 2022Drug	CLASS I	Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial recalledVeklury	Gilead Sciences	Particulate Matter	Nationwide

Should you stop taking Remdesivir?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.